日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromes

瑞士一组急性冠脉综合征患者的教育水平、临床结果和护理质量

Achard, Maëlle; Follonier, Cédric; Fournier, Evelyne; Carballo, David; Branca, Mattia; Heg, Dik; Nanchen, David; Räber, Lorenz; Klingenberg, Roland; Windecker, Stephan; Lüscher, Thomas F; Matter, Christian M; Rodondi, Nicolas; Mach, François; Gencer, Baris

Association Between Patient Sex and Familial Hypercholesterolemia and Long-Term Cardiovascular Risk Factor Management 5 Years After Acute Coronary Syndrome

急性冠脉综合征后5年,患者性别、家族性高胆固醇血症与长期心血管危险因素管理之间的关联

Krasieva, Kristina; Gencer, Baris; Locatelli, Isabella; Carballo, David; Muller, Olivier; Fournier, Stéphane; Matter, Christian M; Räber, Lorenz; Rodondi, Nicolas; Mach, François; Nanchen, David

Eligibility for marine omega-3 fatty acid supplementation after acute coronary syndromes

急性冠脉综合征后补充海洋来源ω-3脂肪酸的资格

Follonier, Cédric; Rabassa, Gabriel; Branca, Mattia; Carballo, David; Koskinas, Konstantinos; Heg, Dik; Nanchen, David; Räber, Lorenz; Klingenberg, Roland; Haller, Moa Lina; Carballo, Sebastian; Windecker, Stephan; Matter, Christian M; Rodondi, Nicolas; Mach, François; Gencer, Baris

A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors

针对晚期实体瘤患者的个性化主动免疫疗法 MVX-ONCO-1 首次人体 I 期临床研究

Rémi Vernet #, Eugenio Fernandez #, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio De Vito, Jessica Renaux, Jean Villard, Olivier Rubin #, Julien Grogg, Nicolas Mach

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

使用 Durvalumab 进行围手术期化学免疫治疗治疗肌层浸润性尿路上皮癌:单组 II 期试验 SAKK 06/17 的初步分析

Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz, Lukas Bubendorf, Berna C Özdemir, Bernhard Kiss, Andreas Erdmann, Stefanie Aeppli, Nicolas Mach, Räto T Strebel, Boris Hadaschik, Dominik Berthold, Hubert John, Deborah Zihler, Mathias Schmid, Ilaria Alborelli, Martina Schneider, Jana Musilova, M

Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins

设计一种用途广泛且可回收的细胞大囊化装置,用于递送治疗性蛋白质

Julien Grogg ,Remi Vernet ,Emily Charrier ,Muriel Urwyler ,Olivier Von Rohr ,Valentin Saingier ,Fabien Courtout ,Aurelien Lathuiliere ,Nicolas Gaudenzio ,Adrien Engel ,Nicolas Mach

Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology

利用封装细胞技术,永生化人类成肌细胞系用于递送治疗性蛋白质

Aurelien Lathuiliere, Remi Vernet, Emily Charrier, Muriel Urwyler, Olivier Von Rohr, Marie-Claude Belkouch, Valentin Saingier, Thomas Bouvarel, Davy Guillarme, Adrien Engel, Patrick Salmon, Thomas Laumonier, Julien Grogg, Nicolas Mach

Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes

富含半胱氨酸的血管生成诱导剂 61 可提高 GRACE(全球急性冠脉事件注册研究)2.0 风险评分在急性冠脉综合征患者中的预后准确性

Klingenberg, Roland; Aghlmandi, Soheila; Räber, Lorenz; Akhmedov, Alexander; Gencer, Baris; Carballo, David; Nanchen, David; Bucher, Heiner C; Rodondi, Nicolas; Mach, François; Windecker, Stephan; Landmesser, Ulf; von Eckardstein, Arnold; Hamm, Christian W; Lüscher, Thomas F; Matter, Christian M

A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein

检测针对 SARS-CoV-2 刺突蛋白的特异性人类 IgG 的定量 ELISA 方案

Rémi Vernet, Emily Charrier, Julien Grogg, Nicolas Mach

Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model

通过基因工程包裹细胞进行局部持续 GM-CSF 输送,在实验性小鼠刺突 DNA 疫苗接种模型中增强了细胞和体液 SARS-CoV-2 刺突特异性免疫反应

Rémi Vernet, Emily Charrier, Erika Cosset, Sabine Fièvre, Ugo Tomasello, Julien Grogg, Nicolas Mach